Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$19.34 +0.35 (+1.87%)
As of: Oct 2, 2026 · 12:40 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Assets (2013 - 2026)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) recorded Other Non-Current Assets of $1.11 million in Q2 2026, up 120.0% from $506,000 a year earlier and up 25.3% from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Viridian Therapeutics, Inc.\DE reported Other Non-Current Assets of $1.54 million, up 206.6% from FY2024.

  • Annual Other Non-Current Assets has a five-year compound annual growth rate of 333.8% (FY2020 to FY2025).
  • Across earlier years, Other Non-Current Assets came in at $501,000 in FY2024 (-17.1%), $604,000 in FY2023 (-38.5%), $982,000 in FY2022 (-34.1%) and $1.49 million in FY2021.
  • Quarterly Other Non-Current Assets has ranged from $489,000 in Q1 2025 to $1.54 million in Q1 2022 over the past five years.
  • On a year-over-year basis, Other Non-Current Assets has increased for four consecutive quarters, with growth averaging 50.2% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 206.6% in Q4 2025, against a decline of 44.3% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $888,000 (Q1 2026), $1.54 million (Q4 2025) and $1.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Viridian Therapeutics, Inc.\DE 2.33 Bn 2.33 Bn - 1.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Mn
Mar 31, 2026 888,000.00
Dec 31, 2025 1.54 Mn
Sep 30, 2025 1.52 Mn
Jun 30, 2025 506,000.00
Mar 31, 2025 489,000.00
Dec 31, 2024 501,000.00
Sep 30, 2024 853,000.00
Jun 30, 2024 659,000.00
Mar 31, 2024 555,000.00
Dec 31, 2023 604,000.00
Sep 30, 2023 1.26 Mn
Jun 30, 2023 1.18 Mn
Mar 31, 2023 982,000.00
Dec 31, 2022 982,000.00
Sep 30, 2022 1.15 Mn
Jun 30, 2022 1.51 Mn
Mar 31, 2022 1.54 Mn
Dec 31, 2021 1.49 Mn
Sep 30, 2021 1.46 Mn
API Access

Viridian Therapeutics, Inc.\DE Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VRDN&period=max&api_key=YOUR_API_KEY